Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Protocol for assessment of capecitabine for advanced colorectal cancer in patients aged 70 years and older (and in a cohort of patients younger than 60 years)

Trial Profile

Protocol for assessment of capecitabine for advanced colorectal cancer in patients aged 70 years and older (and in a cohort of patients younger than 60 years)

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2014

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Colorectal cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 29 May 2008 Status changed from in progress to completed, as reported on clinicaltrials.gov
    • 17 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top